Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Get essential year-end tax filing guidance for DRIP ETFs, including records to gather and strategies to reduce liabilities.
24,400 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
XRP’s on-chain activity has cooled to a rare lull even as the price slips. New wallet signups and active addresses re...
BAI has surged 61% over the trailing year but faced a midweek pullback. Here are two signals that will determine whet...
Fidelity's Dividend ETF for Rising Rates has surged 23% over the last year, but the fund’s tech-heavy, rate-sensitive...
Two quantum computing stocks with upside projections have caught the eye of Wall Street. This guide breaks down why t...
A small starter can unlock big, compounding growth. Learn how to pick a durable consumer stock with a $1,000 investme...
Silver prices have swung wildly and the SLV ETF has fallen in recent months. This guide breaks down what’s driving th...
In a volatile rate environment, DIVO remains a focal point for income investors. This report analyzes payout stabilit...
AI chip headlines are steering market moves this June. From Google’s foundry ambitions to Intel's refreshed strategy,...
Bank on a nuclear surge in 2026? URNM and URA offer different routes to exposure. This piece breaks down urnm: which ...
Three key ETFs are steering the reshoring trend in critical minerals as China tightens export controls. REMX, LIT, an...
The NEOS Nasdaq-100 High Income ETF (QQQI) currently yields almost 14%, drawing income seekers. But can this strategy...